wellrank.ai
Sign In

I want to move my Ozempic care from my doctor to a telehealth service. Which one?

ClaudeswitchingCollected Jul 24, 2026, 09:40 UTC

Verbatim response from Claude

Here are some solid telehealth options for Ozempic/GLP-1 management:

Top Recommendations

Ro (ro.co)

  • Well-established platform with licensed physicians
  • Handles prior authorizations and pharmacy coordination
  • Good ongoing support and follow-up care

Hims & Hers

  • Easy onboarding process
  • Offers both branded Ozempic and compounded semaglutide options
  • Competitive pricing tiers

Noom Med

  • Combines medication management with behavioral coaching
  • Good if you want a more comprehensive weight loss program

Found

  • Focuses specifically on weight care
  • Assigns a dedicated care team
  • Strong app for tracking

Things to Consider

  • Insurance - Check which platforms work with your plan, as Ozempic can be $900+/month out of pocket
  • Compounded vs. branded - Some services offer compounded semaglutide at lower cost, but be aware of ongoing FDA regulatory changes around this
  • Prior authorization support - Make sure they'll handle the paperwork burden

My Top Pick

Ro tends to have the most seamless experience for transitioning existing patients and has strong physician oversight.

Would you like help thinking through insurance coverage or cost considerations?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.